Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + GTP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + GDP + phosphate
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ITP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + IDP + phosphate
additional information
?
-
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O

beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: favoured reaction
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: favoured reaction
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
r, ?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
r, ?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: the pyridine N and carboxyl groups are important for interaction with the enzyme
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: in the presence of Mg2+ and inorganic phosphate
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: lack of the de novo pathway for NAD+ synthesis from tryptophan, utilizes both nicotinic acid and nicotinamide as NAD+ precursors
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: first step in NAD+-(salvage) biosynthesis
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: NAPRT is essential for nicotinic acid to increase cellular NAD levels and thus to prevent oxidative stress of the cells
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: + whole cell lysates, pH 7.5, 37°C, 10 mM MgCl2, 2.5 mM dithiothreitol, 1 mM ATP, 25 microgram bovine serum albumin, with or without NAD+
Products: termination by boiling for 60 seconds, analysis by thin layer chromatography (radiolabeled nicotinic acid) or ESI-MS, no NaMN detectable in Hep-G2 cells
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: first step in NAD+-(salvage) biosynthesis
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: essential for the NAD salvage pathway
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: the enzyme is a facultative ATPase that uses ATP hydrolysis to drive the synthesis of nicotinate mononucleotide and diphosphate from nicotinic acid and phosphoribosyl diphosphate in a steady-state reaction, the enzyme undergoes phosphorylation in His-219 by bound ATP, phosphorylated enzyme has higher affinity for substrates than does nonphosphorylated enzyme
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: the enzyme is a facultative ATPase that uses ATP hydrolysis to drive the synthesis of nicotinate mononucleotide and diphosphate from nicotinic acid and phosphoribosyl diphosphate in a steady-state reaction, the enzyme undergoes phosphorylation in His-219 by bound ATP, phosphorylated enzyme has higher affinity for substrates than does nonphosphorylated enzyme
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: mutants in the His-219 residue do catalyze the slow formation of nicotinic acid mononucleotide in the absence of ATP similarly to the wild type enzymes
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: no phosphoribosylation of nicotinamide, quinolic acid, adenine or hypoxanthine
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + GTP + H2O

beta-nicotinate D-ribonucleotide + diphosphate + GDP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + GTP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + GDP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ITP + H2O

beta-nicotinate D-ribonucleotide + diphosphate + IDP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ITP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + IDP + phosphate
-
Substrates: 5-phospho-alpha-D-ribose 1-diphosphate in complex with Mg
Products: -
?
additional information

?
-
-
Substrates: one mol ATP is cleaved per mol product formed
Products: -
?
additional information
?
-
-
Substrates: one mol ATP is cleaved per mol product formed
Products: -
?
additional information
?
-
-
Substrates: one mol ATP is cleaved per mol product formed
Products: -
?
additional information
?
-
-
Substrates: one mol ATP is cleaved per mol product formed
Products: -
?
additional information
?
-
-
Substrates: no ATPase activity in the absence of substrates
Products: -
?
additional information
?
-
-
Substrates: no ATPase activity in the absence of substrates
Products: -
?
additional information
?
-
Substrates: nicotinamide is not substrate
Products: -
?
additional information
?
-
-
Substrates: nicotinamide is not substrate
Products: -
?
additional information
?
-
Substrates: quinolinic acid is not substrate
Products: -
?
additional information
?
-
-
Substrates: quinolinic acid is not substrate
Products: -
?
additional information
?
-
-
Substrates: enzyme is able to generate adenosine 5'-tetraphosphate using substrate ATP and product phosphate, reaction of EC 3.6.1.14. Accompanying a typically irreversible hydrolysis of ATP to ADP and phosphate, is a fully reversible phosphate transfer reaction between ATP and adenosine 5'-tetraphosphate
Products: -
?
additional information
?
-
Substrates: -
Products: -
?
additional information
?
-
-
Substrates: -
Products: -
?
additional information
?
-
-
Substrates: ATP and phosphoribose diphosphate compete for ATP-binding site
Products: -
?
additional information
?
-
-
Substrates: ATPase activity in the presence of either product and in the absence of phosphoribose diphosphate
Products: -
?
additional information
?
-
Substrates: molecular evolution mechanism
Products: -
?
additional information
?
-
-
Substrates: molecular evolution mechanism
Products: -
?
additional information
?
-
-
Substrates: negligible ATPase activity in the absence of nicotinic acid
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
additional information
?
-
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O

beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: lack of the de novo pathway for NAD+ synthesis from tryptophan, utilizes both nicotinic acid and nicotinamide as NAD+ precursors
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: first step in NAD+-(salvage) biosynthesis
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: NAPRT is essential for nicotinic acid to increase cellular NAD levels and thus to prevent oxidative stress of the cells
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: -
Products: -
r
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: -
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
-
Substrates: first step in NAD+-(salvage) biosynthesis
Products: -
?
nicotinate + 5-phospho-alpha-D-ribose 1-diphosphate + ATP + H2O
beta-nicotinate D-ribonucleotide + diphosphate + ADP + phosphate
Substrates: essential for the NAD salvage pathway
Products: -
r
additional information

?
-
Substrates: molecular evolution mechanism
Products: -
?
additional information
?
-
-
Substrates: molecular evolution mechanism
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Bone Marrow Failure Disorders
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Carcinoma
Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Carcinoma, Non-Small-Cell Lung
Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Glioblastoma
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner.
Glioblastoma
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.
Glioma
NAD+ depletion radiosensitizes 2-DG-treated glioma cells by abolishing metabolic adaptation.
Glucose Intolerance
Tissue-specific regulation of sirtuin and nicotinamide adenine dinucleotide biosynthetic pathways identified in C57Bl/6 mice in response to high-fat feeding.
Lymphoma
Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas.
Neoplasms
A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor.
Neoplasms
Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylation.
Neoplasms
Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Neoplasms
Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.
Neoplasms
Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors.
Neoplasms
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner.
Neoplasms
NAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples.
Neoplasms
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Neoplasms
Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
Neoplasms
Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression.
Neoplasms
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Neoplasms
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.
Neuroblastoma
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner.
Neuroblastoma
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.
nicotinate phosphoribosyltransferase deficiency
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.
Ovarian Neoplasms
Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Sarcoma
Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner.
Sarcoma
The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D19A
activity completely abolished
D288A
about 10% of wild type activity
G169A
about 40% of wild type activity
G209A
about 20% of wild type activity
G379A
activity completely abolished
N357A
about 80% of wild type activity
R318A
activity strictly dependent on the presence of ATP
S381A
about 40% of wild type activity
T380A
about 50% of wild type activity
Y21A
activity strictly dependent on the presence of ATP
A323V
mutation identified from whole-genome sequenced data
F286V
mutation identified from whole-genome sequenced data
G429A
mutation has stabilizing effects on the protein structure
S120L
mutation localized in the loop region, leads to a gain in flexibility in the surrounding residues
A323V
-
mutation identified from whole-genome sequenced data
-
F286V
-
mutation identified from whole-genome sequenced data
-
G127S
-
mutation identified from whole-genome sequenced data
-
S120L
-
mutation localized in the loop region, leads to a gain in flexibility in the surrounding residues
-
P21L
mutation identified in a strain with early leaf sensescence, mutation causes the expression of the gene at the transcriptional level to decline by 40% in fully expanded leaves. Leaf nicotinate and nicotinamide contents are elevated, while NAD levels are reduced. Leaf tissue of P21L exhibits significant DNA fragmentation and H2O2 accumulation, along with up-regulation of genes associated with senescence. The mutant also shows reduced expression of SIR2-like genes SRT1 and SRT2 and increased acetylation of histone H3K9
H213A

about 50% of wild type activity
H213A
-
mutant is unable to generate adenosine 5'-tetraphosphate
G127S

mutation identified from whole-genome sequenced data
G127S
mutation has stabilizing effects on the protein structure
P447S

mutation identified from whole-genome sequenced data
P447S
mutation localized in the loop region, leads to a gain in flexibility in the surrounding residues
P447S

-
mutation identified from whole-genome sequenced data
-
P447S
-
mutation localized in the loop region, leads to a gain in flexibility in the surrounding residues
-
additional information

analysis of whole-genome sequenced data. Among the 287 data sets, 230 harbored mutations in isoform PncB1, 36 contain mutations in PncB2 and 21 samples remained wild type for both. The most common mutations detected in PncB1 are Pro447Ser (ccg/Tcg), Gly429Ala (ggc/gCc) and eight nucleotide deletions at genomic position 1499213-1499220, the most common non-synonymous mutations exhibit stabilizing effects on the PncB1 structure
additional information
analysis of whole-genome sequenced data. Among the 287 data sets, 230 harbored mutations in isoform PncB1, 36 contain mutations in PncB2 and 21 samples remained wild type for both. The most common mutations detected in PncB1 are Pro447Ser (ccg/Tcg), Gly429Ala (ggc/gCc) and eight nucleotide deletions at genomic position 1499213-1499220, the most common non-synonymous mutations exhibit stabilizing effects on the PncB1 structure
additional information
analysis of whole-genome sequenced data. Among the 287 data sets, 230 harbored mutations in isoform PncB1, 36 contain mutations in PncB2 and 21 samples remained wild type for both
additional information
analysis of whole-genome sequenced data. Among the 287 data sets, 230 harbored mutations in isoform PncB1, 36 contain mutations in PncB2 and 21 samples remained wild type for both
additional information
-
analysis of whole-genome sequenced data. Among the 287 data sets, 230 harbored mutations in isoform PncB1, 36 contain mutations in PncB2 and 21 samples remained wild type for both. The most common mutations detected in PncB1 are Pro447Ser (ccg/Tcg), Gly429Ala (ggc/gCc) and eight nucleotide deletions at genomic position 1499213-1499220, the most common non-synonymous mutations exhibit stabilizing effects on the PncB1 structure
-
additional information
-
analysis of whole-genome sequenced data. Among the 287 data sets, 230 harbored mutations in isoform PncB1, 36 contain mutations in PncB2 and 21 samples remained wild type for both
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Imsande, J.
Pathway of diphosphopyridine nucleotide biosynthesis in Escherichia coli
J. Biol. Chem.
236
1494-1497
1961
Escherichia coli
brenda
Imsande, J.; Handler, P.
Biosynthesis of diphosphopyridine nucleotide. III. Nicotinic acid mononucleotide pyrophosphorylase
J. Biol. Chem.
236
525-530
1961
Bos taurus
brenda
Kosaka, A.; Spivey, H.O.; Gholson, R.K.
Nicotinate phosphoribosyltransferase of yeast. Purification and properties
J. Biol. Chem.
246
3277-3283
1971
Saccharomyces cerevisiae
brenda
Gaut, Z.N.; Solomon, H.M.
Inhibition of nicotinate phosphoribosyltransferase in human platelet lysate by nicotinic acid analogs
Biochem. Pharmacol.
20
2903-2906
1971
Homo sapiens
brenda
Niedel, J.; Dietrich, L.S.
Nicotinate phosphoribosyltransferase of human erythrocytes. Purification and properties
J. Biol. Chem.
248
3500-3505
1973
Homo sapiens
brenda
Hanna, L.S.; Hess, S.L.; Sloan, D.L.
Kinetic analysis of nicotinate phosphoribosyltransferase from yeast using high pressure liquid chromatography
J. Biol. Chem.
258
9745-9754
1983
Saccharomyces cerevisiae
brenda
Hayakawa, T.; Shibata, K.; Iwai, K.
Purification and some properties of nicotinate phosphoribosyltransferase from hog liver
Agric. Biol. Chem.
48
445-453
1984
Sus scrofa, Rattus norvegicus, Rattus norvegicus male Wistar
-
brenda
Hayakawa, T.; Shibata, K.; Iwai, K.
Nicotinate phosphoribosyltransferase from hog liver: regulatory effect of ATP at a physiological concentrations of 5-phosphoribosyl-1-pyrophosphte
Agric. Biol. Chem.
48
455-460
1984
Sus scrofa, Rattus norvegicus
-
brenda
Kosaka, A.; Spivey, H.O.; Gholson, R.K.
Yeast nicotinic acid phosphoribosyltransferase. Studies of reaction paths, phosphoenzyme, and Mg2+ effects
Arch. Biochem. Biophys.
179
334-341
1977
Saccharomyces cerevisiae
brenda
Imsande, J.
A cross-linked control system. I. Properties of a triphosphate-dependent nicotinic acid mononucleotide pyrophosphorylase from Bacillus subtilis
Biochim. Biophys. Acta
85
255-264
1964
Bacillus subtilis, Bacillus subtilis SB19
brenda
Gross, J.W.; Rajavel, M.; Grubmeyer, C.
Kinetic mechanism of nicotinic acid phosphoribosyltransferase. Implications for energy coupling
Biochemistry
37
4189-4199
1998
Salmonella enterica subsp. enterica serovar Typhimurium
brenda
Rajavel, M.; Lalo, D.; Gross, J.W.; Grubmeyer, C.
Conversion of a cosubstrate to an inhibitor. Phosphorylation mutants of nicotinic acid phosphoribosyltransferase
Biochemistry
37
4181-4188
1998
Saccharomyces cerevisiae (P39683), Saccharomyces cerevisiae, Salmonella enterica subsp. enterica serovar Typhimurium
brenda
Rajavel, M.; Gross, J.W.; Segura, E.; Moore, W.T.; Grubmeyer, C.
Limited proteolysis of Salmonella typhimurium nicotinic acid phosphoribosyltransferase reveals ATP-linked conformational change
Biochemistry
35
3909-3916
1996
Salmonella enterica subsp. enterica serovar Typhimurium
brenda
Vinitsky, A.; Grubmeyer, C.
A new paradigm for biochemical energy coupling. Salmonella typhimurium nicotinate phosphoribosyltransferase
J. Biol. Chem.
268
26004-26010
1993
Salmonella enterica subsp. enterica serovar Typhimurium
brenda
Pescaglini, M.; Micheli, V.; Simmonds, H.A.; Rocchigiani, M.; Pompucci, G.
Nicotinic acid phosphoribosyltransferase activity in human erythtocytes: studies using a niw HPLC method
Clin. Chim. Acta
229
15-25
1994
Homo sapiens
brenda
Grubmeyer, C.T.; Gross, J.W.; Rajavel, M.
Energy coupling through molecular discrimination: nicotinate phosphoribosyltransferase
Methods Enzymol.
308
28-48
1999
Mycobacterium tuberculosis (P9WJW5), Mycobacterium tuberculosis H37Rv (P9WJW5), Saccharomyces cerevisiae, Saccharomyces cerevisiae (P39683), Salmonella enterica subsp. enterica serovar Typhimurium (P22253)
brenda
Shin, D.H.; Oganesyan, N.; Jancarik, J.; Yokota, H.; Kim, R.; Kim, S.H.
Crystal structure of a nicotinate phosphoribosyltransferase from Thermoplasma acidophilum
J. Biol. Chem.
280
18326-18335
2005
Thermoplasma acidophilum (Q9HJ28), Thermoplasma acidophilum
brenda
Chappie, J.S.; Canaves, J.M.; Han, G.W.; Rife, C.L.; Xu, Q.; Stevens, R.C.
The structure of a eukaryotic nicotinic acid phosphoribosyltransferase reveals structural heterogeneity among type II PRTases
Structure
13
1385-1396
2005
Saccharomyces cerevisiae (P39683), Saccharomyces cerevisiae
brenda
Hara, N.; Yamada, K.; Shibata, T.; Osago, H.; Hashimoto, T.; Tsuchiya, M.
Elevation of cellular NAD levels by nicotinic acid and involvement of nicotinic acid phosphoribosyltransferase in human cells
J. Biol. Chem.
282
24574-24582
2007
Homo sapiens (Q6XQN6), Homo sapiens, Mus musculus, Mus musculus (Q8CC86), Rattus norvegicus (Q6XQN1), Mus musculus BALB/c (Q8CC86)
brenda
Ashihara, H.; Stasolla, C.; Yin, Y.; Loukanina, N.; Thorpe, T.A.
De novo and salvage biosynthetic pathways of pyridine nucleotides and nicotinic acid conjugates in cultured plant cells
Plant Sci.
169
107-114
2005
Picea glauca, Catharanthus roseus
-
brenda
Galassi, L.; Di Stefano, M.; Brunetti, L.; Orsomando, G.; Amici, A.; Ruggieri, S.; Magni, G.
Characterization of human nicotinate phosphoribosyltransferase: Kinetic studies, structure prediction and functional analysis by site-directed mutagenesis
Biochimie
94
300-309
2012
Homo sapiens (Q6XQN6), Homo sapiens
brenda
Liang, L.; Liu, R.; Wang, G.; Gou, D.; Ma, J.; Chen, K.; Jiang, M.; Wei, P.; Ouyang, P.
Regulation of NAD(H) pool and NADH/NAD(+) ratio by overexpression of nicotinic acid phosphoribosyltransferase for succinic acid production in Escherichia coli NZN111
Enzyme Microb. Technol.
51
286-293
2012
Escherichia coli (P18133), Escherichia coli
brenda
Ma, J.; Gou, D.; Liang, L.; Liu, R.; Chen, X.; Zhang, C.; Zhang, J.; Chen, K.; Jiang, M.
Enhancement of succinate production by metabolically engineered Escherichia coli with co-expression of nicotinic acid phosphoribosyltransferase and pyruvate carboxylase
Appl. Microbiol. Biotechnol.
97
6739-6747
2013
Escherichia coli (P18133), Escherichia coli
brenda
Liu, R.; Liang, L.; Wu, M.; Chen, K.; Jiang, M.; Ma, J.; Wei, P.; Ouyang, P.
CO2 fixation for succinic acid production by engineered Escherichia coli co-expressing pyruvate carboxylase and nicotinic acid phosphoribosyltransferase
Biochem. Eng. J.
79
77-83
2013
Escherichia coli
-
brenda
Jiang, M.; Chen, X.; Liang, L.; Liu, R.; Wan, Q.; Wu, M.; Zhang, H.; Ma, J.; Chen, K.; Ouyang, P.
Co-expression of phosphoenolpyruvate carboxykinase and nicotinic acid phosphoribosyltransferase for succinate production in engineered Escherichia coli
Enzyme Microb. Technol.
56
8-14
2013
Escherichia coli
brenda
Marletta, A.S.; Massarotti, A.; Orsomando, G.; Magni, G.; Rizzi, M.; Garavaglia, S.
Crystal structure of human nicotinic acid phosphoribosyltransferase
FEBS Open Bio
5
419-428
2015
Homo sapiens (Q6XQN6), Homo sapiens
brenda
Piacente, F.; Caffa, I.; Ravera, S.; Sociali, G.; Passalacqua, M.; Vellone, V.G.; Becherini, P.; Reverberi, D.; Monacelli, F.; Ballestrero, A.; Odetti, P.; Cagnetta, A.; Cea, M.; Nahimana, A.; Duchosal, M.; Bruzzone, S.; Nencioni, A.
Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors, and DNA repair
Cancer Res.
77
3857-3869
2017
Homo sapiens (Q6XQN6)
brenda
Amici, A.; Grolla, A.A.; Del Grosso, E.; Bellini, R.; Bianchi, M.; Travelli, C.; Garavaglia, S.; Sorci, L.; Raffaelli, N.; Ruggieri, S.; Genazzani, A.A.; Orsomando, G.
Synthesis and degradation of adenosine 5-tetraphosphate by nicotinamide and nicotinate phosphoribosyltransferases
Cell Chem. Biol.
24
553-564
2017
Homo sapiens
brenda
Duarte-Pereira, S.; Pereira-Castro, I.; Silva, S.S.; Correia, M.G.; Neto, C.; da Costa, L.T.; Amorim, A.; Silva, R.M.
Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors
Oncotarget
7
1973-1983
2016
Homo sapiens
brenda
Wu, L.; Ren, D.; Hu, S.; Li, G.; Dong, G.; Jiang, L.; Hu, X.; Ye, W.; Cui, Y.; Zhu, L.; Hu, J.; Zhang, G.; Gao, Z.; Zeng, D.; Qian, Q.; Guo, L.
Down-regulation of a nicotinate phosphoribosyltransferase gene, OsNaPRT1, leads to withered leaf tips
Plant Physiol.
171
1085-1098
2016
Oryza sativa Japonica Group (Q851M0)
brenda
He, J.; Liu, X.; Xia, J.; Xu, J.; Xiong, P.; Qiu, Z.
One-step utilization of non-detoxified pretreated lignocellulose for enhanced cellulolytic enzyme production using recombinant Trichoderma reesei RUT C30 carrying alcohol dehydrogenase and nicotinate phosphoribosyltransferase
Biores. Technol.
310
123458
2020
Trichoderma reesei (A0A024S5F4), Trichoderma reesei ATCC 56765 (A0A024S5F4)
brenda
Manago, A.; Audrito, V.; Mazzola, F.; Sorci, L.; Gaudino, F.; Gizzi, K.; Vitale, N.; Incarnato, D.; Minazzato, G.; Ianniello, A.; Varriale, A.; DAuria, S.; Mengozzi, G.; Politano, G.; Oliviero, S.; Raffaelli, N.; Deaglio, S.
Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation
Nat. Commun.
10
4116
2019
Homo sapiens (Q6XQN6), Mus musculus (Q8CC86)
brenda
Zhang, Y.; Khan, M.; Lodhi, M.; Al-Amrah, H.; Alrdahe, S.; Alatawi, H.; Darwish, D.
Novel mutations in putative nicotinic acid phosphoribosyltransferases of Mycobacterium tuberculosis and their effect on protein thermodynamic properties
Polymers (Basel)
14
1623
2022
Mycobacterium tuberculosis (P9WJI9), Mycobacterium tuberculosis (P9WJI7), Mycobacterium tuberculosis H37Rv (P9WJI9), Mycobacterium tuberculosis H37Rv (P9WJI7)
brenda